Procurement of Commercial Compounds

The contract titled Procurement of Commercial Compounds under the National Institutes of Health, part of the Department of Health and Human Services, requires sourcing and acquiring commercial chemical and biological compounds from global vendors while rigorously adhering to Good Manufacturing Practices, FDA regulations, customs requirements, and DEA controls. All procured materials must meet stringent quality and compliance standards to ensure safety, legitimacy, and suitability for federally funded research activities. The work is to be performed in Bethesda, with no specified geographic restrictions on vendor locations, but all shipments and documentation must comply with U.S. import and controlled substance laws. The opportunity is classified as a subcontract under NAICS code 424690 and was posted on July 30, 2026, with a response deadline of August 15, 2026. There is no set-aside designation or special procurement category applied, meaning any qualified vendor may respond. The contract does not include specifics on volume, frequency, or exact compound types, implying flexibility in sourcing but demanding strict adherence to regulatory frameworks throughout the supply chain. The procurement process is managed through the SAM.gov platform, and timely submission is essential to be considered for award.